DEFINIENDO EL CANDIDATO A RECIBIR ENZALUTAMIDA, INHIBIDOR DIRECTO DEL RECEPTOR DE ANDRÓGENOS Dra. Cristina Suárez Hospital Universitari Vall d´Hebron-VHIO.
It has now been established that T2DM is an independent risk factor for osteoporotic fractures. 1 It has now been established that T2DM is an independent.
Management Advances for Differentiated and Medullary Thyroid Carcinoma
